Skip to content

Kiwi Biosciences

YC S21 · Active · Patent-pending enzymes to break down common dietary triggers

Competitors

Adjacent

Also from S21

All of S21

About Kiwi Biosciences

Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
Other
Team size
10
Location
Boston, MA, USA
Checked
36m ago

YC tags: Biotech, Food Tech

Kiwi Biosciences in S21: 391 companies, 34% AI

Kiwi Biosciences: questions

Which YC batch was Kiwi Biosciences in?

Kiwi Biosciences was in Y Combinator's Summer 2021 batch (S21).

Is Kiwi Biosciences still active?

Y Combinator lists Kiwi Biosciences as active.

Where is Kiwi Biosciences based?

Kiwi Biosciences lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.